ISSN: 2319-7064
Research Paper | Pharmaceutical Science | India | Volume 8 Issue 11, November 2019
Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism
Thrishankareddy P
New oral anticoagulants (NOAC; rivaroxaban, dabigatran, apixaban) have become available as an alternative to warfarin anticoagulation in peripheral venous thromboembolism. We assessed the effectiveness and safety along with side effects of rivaroxaban vs warfarin in patients experiencing venous thromboembolism (both deep vein thrombosis and pulmonary embolism)
Keywords: Venous thromboembolism, Warfarin, Rivaroxaban, Bleeding
Edition: Volume 8 Issue 11, November 2019
Pages: 222 - 232
How to Cite this Article?
Thrishankareddy P, "Comparative Clinical Study of Warfarin and Rivaroxaban (Newer Anti-Coagulant) with Respect to Efficacy and Side Effects in the Treatment of Peripheral Venous Thromboembolism", International Journal of Science and Research (IJSR), https://www.ijsr.net/search_index_results_paperid.php?id=ART20202436, Volume 8 Issue 11, November 2019, 222 - 232
